New York State Common Retirement Fund’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,100
Closed -$348K 3331
2020
Q4
$348K Sell
15,100
-600
-4% -$13.8K ﹤0.01% 2522
2020
Q3
$160K Hold
15,700
﹤0.01% 2751
2020
Q2
$234K Buy
15,700
+6,600
+73% +$98.4K ﹤0.01% 2571
2020
Q1
$111K Hold
9,100
﹤0.01% 2728
2019
Q4
$144K Buy
9,100
+8,300
+1,038% +$131K ﹤0.01% 2886
2019
Q3
$10K Buy
+800
New +$10K ﹤0.01% 3215